The startup develops an ultrasound-based positioning detection system for accurate nasogastric tube placement in enteral feeding procedures. This technology enhances safety and efficiency by minimizing the risk of misplacement, reducing costs, and eliminating the need for harmful radiation exposure.
Funding
$430K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for confirming nasogastric tube (NGT) placement, such as pH aspirates and X-rays, have limitations, leading to potential misplacements. pH aspirates are not always obtainable, and X-ray interpretation errors can occur, increasing the risk of complications during enteral feeding. These inaccuracies can compromise patient safety and increase healthcare costs.
Solution
Nasotrak Medical offers an ultrasound-based NGT positioning system designed to accurately detect the distal end of the NGT within the stomach. The system uses a handheld device connected to a proprietary NG tube. As the caregiver scans the abdominal region, the device provides real-time visual and auditory feedback, indicating whether the tube is correctly placed. This technology aims to improve the safety and efficiency of enteral feeding by reducing the reliance on less reliable methods and eliminating radiation exposure.
Target Audience
The primary target audience includes caregivers and healthcare professionals involved in enteral feeding procedures in hospitals, nursing homes, and home healthcare settings.
Features
- Ultrasound-based detection of NGT placement
- Handheld device with light and sound indicators for real-time feedback
- Proprietary NG tube designed for use with the Nasotrak system
- Planned scanning path to guide caregivers during the placement check
- Green light indicator for correct placement in the stomach
- Red light indicator for incorrect placement